Delivery Order SPE2DB22D1106-SPE2DB25FFDM5
- Not listed
- The Defense Logistics Agency awarded a $43,815.44 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Neulasta OnPro 6 mg/0.6 mL kits. The contract represents a firm fixed price, non-competitive set-aside award with an ultimate completion date of April 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,231.59 to AmerisourceBergen Drug Corp for Neulasta OnPro 6 mg/0.6 mL kits on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price, non-set-aside delivery order represents a pharmaceutical supply transaction under a competitively awarded contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,389.54 to AmerisourceBergen Drug Corp for the supply of Neulasta Onpro 6 mg/0.6 ml injectable kits, with an ultimate completion date of December 4, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,530.76 to AmerisourceBergen Drug Corp for Neulasta Onpro 6 mg/0.6 ml kits on September 9, 2025, with completion scheduled for September 10, 2025. The award utilized firm fixed pricing with no set-aside designation, indicating competitive selection among eligible contractors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate...
- The Defense Logistics Agency awarded a $28,076.54 delivery order to AmerisourceBergen Drug Corp for Neulasta 6 mg/0.6 ml syringes on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $10,026.36 for Neulasta 6 mg/0.6 mL syringes, with completion targeted for August 7, 2025. The contract, issued on August 6, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,438.72 to AmerisourceBergen Drug Corp for Neulasta 6 mg/0.6 ml syringes on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with no set-aside...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Neulasta OnPro 6 mg/0.6 ml kits. The order, valued at $6,176.80, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp provides pharmaceuticals, medical supplies, and related distribution services to support military treatment programs and facilities under an indefinite delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a medication used to reduce the risk of infection in cancer patients undergoing chemotherapy. The contract has a ceiling value of $13,074.00 and a completion date of July 10, 2025. It is a firm fixed-price contract, which indicates the price is...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,831.39, is for the delivery of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialty medication. This contract does not have a set-aside designation, indicating it was competed openly. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDM5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18.7K to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Neulasta OnPro 6 mg/0.6 mL kits. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Neulasta is a specialty pharmaceutical product used to support patient recovery following chemotherapy treatments, representing a critical medical supply component within the federal pharmaceutical procurement portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products, specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's consistent performance on competitively awarded federal contracts demonstrates its capability to fulfill critical medical supply requirements for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 8/14/25 |